Forbes
As Seen In: Forbes
Five Health Tech Developments: Continued Profits and Pressure for PBMs
As the lack of transparency from PBMs continues to generate debate, the call for reform has never been…
As Seen In: Forbes
Drug Price Transparency Stymies Consumers, New Survey Shows
As Deb Gordon writes in Forbes about our Pharmacy Trends survey, “…90% of survey respondents said they would appreciate…